REPORTS

Let’s Pullulate and Expand Your Business

Anticoagulants Market - Global Professional Analysis and Forecast to 2026

Jan 16, 2020  |  219 PAGES  |  REPORT CODE: CMM261738
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Anticoagulants market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.8% during the forecast period.

This report presents the market size and development trends by detailing the Anticoagulants market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Anticoagulants market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Anticoagulants industry and will help you to build a panoramic view of the industrial development.

Anticoagulants Market, By Type:

  • Platelet aggregation inhibitors (PAI)

  • Low-molecular-weight Heparin (LMWH)

  • Direct thrombin inhibitor (DTI)

  • Direct factor Xa inhibitors (DFXa)

  • Vitamin K antagonists (VKA)

  • Others

Anticoagulants Market, By Application:

  • VTE

  • ACS/MI

  • AF

  • Others

Some of the leading players are as follows:

  • Sanofi

  • Lilly

  • Aspen

  • Boehringer Ingelheim

  • Pfizer

  • AstraZeneca

  • Johnson & Johnson

  • Daiichi Sankyo

  • Genentech (Roche)

  • Bayer

  • The Medicines Company

  • Bristol-Myers Squibb

  • Otsuka

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Anticoagulants Market: Technology Type Analysis

  • 4.1 Anticoagulants Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Anticoagulants Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Platelet aggregation inhibitors (PAI)

    • 4.3.2 Low-molecular-weight Heparin (LMWH)

    • 4.3.3 Direct thrombin inhibitor (DTI)

    • 4.3.4 Direct factor Xa inhibitors (DFXa)

    • 4.3.5 Vitamin K antagonists (VKA)

    • 4.3.6 Others

5 Anticoagulants Market: Product Analysis

  • 5.1 Anticoagulants Product Market Share Analysis, 2018 & 2026

  • 5.2 Anticoagulants Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Anticoagulants Market: Application Analysis

  • 6.1 Anticoagulants Application Market Share Analysis, 2018 & 2026

  • 6.2 Anticoagulants Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 VTE

    • 6.3.2 ACS/MI

    • 6.3.3 AF

    • 6.3.4 Others

7 Anticoagulants Market: Regional Analysis

  • 7.1 Anticoagulants Regional Market Share Analysis, 2018 & 2026

  • 7.2 Anticoagulants Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Sanofi

    • 9.1.1 Sanofi Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Lilly

    • 9.2.1 Lilly Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Aspen

    • 9.3.1 Aspen Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Boehringer Ingelheim

    • 9.4.1 Boehringer Ingelheim Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Pfizer

    • 9.5.1 Pfizer Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 AstraZeneca

    • 9.6.1 AstraZeneca Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Johnson & Johnson

    • 9.7.1 Johnson & Johnson Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Daiichi Sankyo

    • 9.8.1 Daiichi Sankyo Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Genentech (Roche)

    • 9.9.1 Genentech (Roche) Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Bayer

    • 9.10.1 Bayer Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 The Medicines Company

    • 9.11.1 The Medicines Company Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 Bristol-Myers Squibb

    • 9.12.1 Bristol-Myers Squibb Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 Otsuka

    • 9.13.1 Otsuka Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

 

The List of Tables and Figures (Totals 75 Figures and 124 Tables)

  • Figure Platelet aggregation inhibitors (PAI) Anticoagulants market, 2015 - 2026 (USD Million)

  • Figure Low-molecular-weight Heparin (LMWH) Anticoagulants market, 2015 - 2026 (USD Million)

  • Figure Direct thrombin inhibitor (DTI) Anticoagulants market, 2015 - 2026 (USD Million)

  • Figure Direct factor Xa inhibitors (DFXa) Anticoagulants market, 2015 - 2026 (USD Million)

  • Figure Vitamin K antagonists (VKA) Anticoagulants market, 2015 - 2026 (USD Million)

  • Figure Others Anticoagulants market, 2015 - 2026 (USD Million)

  • Figure VTE market, 2015 - 2026 (USD Million)

  • Figure ACS/MI market, 2015 - 2026 (USD Million)

  • Figure AF market, 2015 - 2026 (USD Million)

  • Figure Others market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Anticoagulants market, by country, 2015 - 2026 (USD Million)

  • Table North America Anticoagulants market, by type, 2015 - 2026 (USD Million)

  • Table North America Anticoagulants market, by product, 2015 - 2026 (USD Million)

  • Table North America Anticoagulants market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Anticoagulants market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Anticoagulants market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Anticoagulants market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Anticoagulants market, by type, 2015 - 2026 (USD Million)

  • Table Canada Anticoagulants market, by product, 2015 - 2026 (USD Million)

  • Table Canada Anticoagulants market, by application, 2015 - 2026 (USD Million)

  • Table Europe Anticoagulants market, by country, 2015 - 2026 (USD Million)

  • Table Europe Anticoagulants market, by type, 2015 - 2026 (USD Million)

  • Table Europe Anticoagulants market, by product, 2015 - 2026 (USD Million)

  • Table Europe Anticoagulants market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Anticoagulants market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Anticoagulants market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Anticoagulants market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Anticoagulants market, by type, 2015 - 2026 (USD Million)

  • Table Germany Anticoagulants market, by product, 2015 - 2026 (USD Million)

  • Table Germany Anticoagulants market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Anticoagulants market, by type, 2015 - 2026 (USD Million)

  • Table France Anticoagulants market, by product, 2015 - 2026 (USD Million)

  • Table France Anticoagulants market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Anticoagulants market, by type, 2015 - 2026 (USD Million)

  • Table Italy Anticoagulants market, by product, 2015 - 2026 (USD Million)

  • Table Italy Anticoagulants market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Anticoagulants market, by type, 2015 - 2026 (USD Million)

  • Table Spain Anticoagulants market, by product, 2015 - 2026 (USD Million)

  • Table Spain Anticoagulants market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Anticoagulants market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Anticoagulants market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Anticoagulants market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Anticoagulants market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Anticoagulants market, by type, 2015 - 2026 (USD Million)

  • Table China Anticoagulants market, by product, 2015 - 2026 (USD Million)

  • Table China Anticoagulants market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Anticoagulants market, by type, 2015 - 2026 (USD Million)

  • Table Japan Anticoagulants market, by product, 2015 - 2026 (USD Million)

  • Table Japan Anticoagulants market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Anticoagulants market, by type, 2015 - 2026 (USD Million)

  • Table India Anticoagulants market, by product, 2015 - 2026 (USD Million)

  • Table India Anticoagulants market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Anticoagulants market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Anticoagulants market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Anticoagulants market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Anticoagulants market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Anticoagulants market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Anticoagulants market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Anticoagulants market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Anticoagulants market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Anticoagulants market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Anticoagulants market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Anticoagulants market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Anticoagulants market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Anticoagulants market, by application, 2015 - 2026 (USD Million)

  • Table MEA Anticoagulants market, by country, 2015 - 2026 (USD Million)

  • Table MEA Anticoagulants market, by type, 2015 - 2026 (USD Million)

  • Table MEA Anticoagulants market, by product, 2015 - 2026 (USD Million)

  • Table MEA Anticoagulants market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Anticoagulants market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Anticoagulants market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Anticoagulants market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Anticoagulants market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Anticoagulants market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Anticoagulants market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Sanofi Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Lilly Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Aspen Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Boehringer Ingelheim Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Pfizer Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table AstraZeneca Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Johnson & Johnson Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Daiichi Sankyo Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Genentech (Roche) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bayer Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table The Medicines Company Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bristol-Myers Squibb Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Otsuka Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top